Characteristics | Â | N (%) | OR (95% CI) | P-value | |
---|---|---|---|---|---|
 | Total | Without lymph node metastasis | With lymph node metastasis | ||
Gender |  |  |  | 0.358(0.197–0.652) | 0.001 * |
Male | 85(45.5) | 28(32.9) | 57(67.1) | Â | Â |
Female | 102(54.4) | 59(57.8) | 43(42.2) | Â | Â |
Age at diagnose(year) |  |  |  | 0.918(0.516–1.634) | 0.771 |
≤ 52 | 101(54.0) | 46(45.5) | 55(54.5) |  |  |
>52 | 86(46.0) | 41(47.7) | 45(52.3) | Â | Â |
Heredity |  |  |  | 2.312(1.089–4.906) | 0.029 * |
Hereditary | 39(20.8) | 12(30.8) | 27(69.2) | Â | Â |
sporadic | 148(79.2) | 75(50.7) | 73(49.3) | Â | Â |
Multifocal |  |  |  | 2.837(1.444–5.572) | 0.002 * |
Yes | 55(29.4) | 16(29.1) | 39(70.9) | Â | Â |
No | 132(70.6) | 71(53.8) | 61(46.2) | Â | Â |
ETE |  |  |  | 2.844(1.542–5.246) | 0.001 * |
Yes | 76(40.6) | 24(31.6) | 52(68.4) | Â | Â |
No | 111(59.4) | 63(56.8) | 48(43.2) | Â | Â |
Bilateral lesions |  |  |  | 1.347(0.524–3.464) | 0.537 |
Yes | 20(10.7) | 8(40.0) | 12(60.0) | Â | Â |
No | 167(89.3) | 79(47.3) | 88(52.7) | Â | Â |
Tumor size(cm) |  |  |  | 1.052(0.646–1.712) | 0.838 |
≤ 2 | 120(64.2) | 56(46.7) | 64(53.3) |  |  |
2–4 | 57(30.5) | 27(47.4) | 30(52.6) |  |  |
>4 | 10(5.3) | 4(40.0) | 6(60.0) | Â | Â |
pT stage |  |  |  | 2.911(1.584–5.350) | 0.001 * |
T1/T2 | 108(57.7) | 62(57.4) | 46(42.6) | Â | Â |
T3/T4 | 79(42.3) | 25(31.6) | 54(68.4) | Â | Â |
Coexist HT |  |  |  | 0.654(0.271–1.579) | 0.345 |
Yes | 24(12.8) | 9(37.5) | 15(62.5) | Â | Â |
No | 163(87.2) | 78(47.9) | 85(52.1) | Â | Â |
IDO2 expression |  |  |  | 8.878(4.403–17.902) | 0.001 * |
High | 77(41.1) | 14(18.2) | 63(81.8) | Â | Â |
Low | 110(58.9) | 73(66.4) | 37(33.6) | Â | Â |